Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.44 Million shares of MRNA, which is worth approximately $53.2 Million. The most recent transaction as insider was on Sep 23, 2020, when has been sold 15,000 shares (Common Stock) at a price of $67.27 per share, resulting in proceeds of $1,009,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44M
0.06% 3M change
8.33% 12M change
Total Value Held $53.2 Million

Stephen Hoge Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 23 2020
SELL
Open market or private sale
$1,009,050 $67.27 p/Share
15,000 Reduced 0.77%
1,931,530 Common Stock
Sep 23 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.51%
1,946,530 Common Stock
Sep 14 2020
SELL
Open market or private sale
$1,242,600 $62.13 p/Share
20,000 Reduced 1.02%
1,936,530 Common Stock
Sep 14 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.51%
1,956,530 Common Stock
Sep 03 2020
SELL
Open market or private sale
$656,500 $65.65 p/Share
10,000 Reduced 0.51%
1,946,530 Common Stock
Sep 03 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.51%
1,956,530 Common Stock
Sep 02 2020
SELL
Open market or private sale
$628,900 $62.89 p/Share
10,000 Reduced 0.51%
1,946,530 Common Stock
Sep 02 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.51%
1,956,530 Common Stock
Aug 24 2020
SELL
Open market or private sale
$1,308,600 $65.43 p/Share
20,000 Reduced 1.02%
1,946,530 Common Stock
Aug 24 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.51%
1,966,530 Common Stock
Aug 13 2020
SELL
Open market or private sale
$1,026,750 $68.45 p/Share
15,000 Reduced 0.76%
1,956,530 Common Stock
Aug 13 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.5%
1,971,530 Common Stock
Aug 12 2020
SELL
Open market or private sale
$357,500 $71.5 p/Share
5,000 Reduced 0.25%
1,961,530 Common Stock
Aug 03 2020
SELL
Open market or private sale
$1,497,800 $74.89 p/Share
20,000 Reduced 1.01%
1,966,530 Common Stock
Aug 03 2020
BUY
Exercise of conversion of derivative security
$19,800 $0.99 p/Share
20,000 Added 1.0%
1,986,530 Common Stock
Jul 24 2020
SELL
Open market or private sale
$354,750 $70.95 p/Share
5,000 Reduced 0.25%
1,966,530 Common Stock
Jul 24 2020
SELL
Open market or private sale
$354,750 $70.95 p/Share
5,000 Reduced 0.25%
1,966,530 Common Stock
Jul 23 2020
SELL
Open market or private sale
$1,185,450 $79.03 p/Share
15,000 Reduced 0.76%
1,971,530 Common Stock
Jul 23 2020
SELL
Open market or private sale
$1,185,450 $79.03 p/Share
15,000 Reduced 0.76%
1,971,530 Common Stock
Jul 23 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.5%
1,986,530 Common Stock
Jul 23 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.5%
1,986,530 Common Stock
Jul 13 2020
SELL
Open market or private sale
$710,700 $71.07 p/Share
10,000 Reduced 0.5%
1,976,530 Common Stock
Jul 13 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.5%
1,986,530 Common Stock
Jul 06 2020
SELL
Open market or private sale
$584,800 $58.48 p/Share
10,000 Reduced 0.5%
1,976,540 Common Stock
Jul 06 2020
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.5%
1,986,540 Common Stock

Also insider at

AXLA
Axcella Health Inc. Healthcare
Stephen Hoge

Stephen Hoge

President
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA